Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ACET
ACET News & Events
-
Add to Watchlist
Trade ACET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
ACET News
Johnson & Johnson Reports Positive Phase 2b Results for Lupus Drug Nipocalimab, Plans Phase 3 Trial
Jan 06 2026
Benzinga
Adicet Bio Announces 1-for-16 Reverse Stock Split to Maintain Listing Compliance
Dec 26 2025
Benzinga
Adicet Bio (ACET) Approves 1-for-16 Reverse Stock Split to Regain Nasdaq Compliance
Dec 26 2025
NASDAQ.COM
Adicet Bio Implements 1-for-16 Reverse Stock Split to Enhance Nasdaq Compliance
Dec 26 2025
Newsfilter
Adicet Bio Announces 1-for-16 Reverse Stock Split, Reducing Shares to 9.6 Million
Dec 26 2025
Businesswire
Adicet Bio Grants New Employee 20,600 Stock Options at $0.65 Each
Nov 28 2025
Newsfilter
Nutex Health Rises 21% in After-Hours Trading Following Revenue Increase; Biotech Competitors Also See Gains on Tuesday
Nov 19 2025
NASDAQ.COM
Guggenheim Upholds Buy Rating for Adicet Bio (ACET)
Oct 09 2025
NASDAQ.COM
Show More News
ACET Events
12/29 20:00
Adicet Bio Trading Halted, News Pending
Adicet Bio trading halted, news pending
Show More Events
ACET Monitor News
No data
ACET Earnings Analysis
No Data
People Also Watch
